MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP

Muc4/MUC4 functions and regulation in cancer

miR-181a negatively regulates NF-κB signaling and affects activated B-cell–like diffuse large B-cell lymphoma pathogenesis

Mechanistic and signaling analysis of Muc4–ErbB2 signaling module: New insights into the mechanism of ligand‐independent ErbB2 activity

Active IKKβ promotes the stability of GLI1 oncogene in diffuse large B-cell lymphoma

LymphomiRs: microRNAs with regulatory roles in lymphomas

A prospective, randomized assessment of a novel, local antibiotic releasing platform for the prevention of superficial and deep surgical site infections

Conformational changes in receptor tyrosine kinase signaling: an ErbB garden of delights

Reduction in surgical site infections by localized administration with D-PLEX100 in patients with multiple risk factors undergoing colorectal surgery

Potent antibacterial activity in surgical wounds with local administration of D-PLEX100

MiR-181a Is a Master Regulator of the Nuclear Factor-κB Signaling Pathway in Diffuse Large B Cell Lymphoma

Reduction in local tumor recurrence in a murine R2 resection model comparing locally administered docetaxel-releasing product, OncoPLEX, versus systemic docetaxel.

Mirna-181a expression Lead to Longer Animal Survival and Slower Tumor-Growth Rate in Diffuse Large B-Cell Lymphoma Xenograft Models

Muc4 modulation of ligand-dependent ErbB2 signaling